This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma Law USA
October 2025
Venue TBCBoston MA

Lulu Wang
Head of Intellectual Property at Orna Therapeutics
Speaker

Profile

Lulu Wang, PhD, is VP, Head of Intellectual Property at Orna Therapeutics, a biotechnology company building new treatments for cancers and genetic diseases. She leads global intellectual property strategy and has over ten years of experience building, defending, and challenging pharmaceutical patent portfolios, as well as conducting patent due diligences for multimillion and multibillion dollar deals.

Prior to joining Orna, Lulu was a patent litigator and prosecutor at Finnegan, representing innovative biotechnology and pharmaceutical companies, including AbbVie, Eli Lilly, and Novartis, in obtaining, defending, and challenging patents in federal court and post-grant proceedings before patent offices. She litigated several of the earliest biosimilars cases under the Biologics Price Competition and Innovation Act (BPCIA), which included navigating the BPCIA patent dance, Purple Book, and parallel patent office proceedings. In 2020, she received Finnegan’s inaugural Mentor of the Year award.

Lulu earned her BA in Biology from Harvard College, PhD in Neurobiology from Harvard Medical School, and JD from Harvard Law School.

Agenda Sessions

  • Focus on Biologics & Biosimilars: Antitrust, IP & Other Issues

    11:10am